Release Notes:
Data Element
Version 2018B1
| Name: | Procoagulant Reversal Agent Initiation |
|---|
| Collected For: |
CSTK-04 |
|---|
| Definition: | A procoagulant reversal agent was initiated at this hospital. Procoagulant reversal agents are medications that increase coagulation factors to promote clotting. |
|---|
| Question: | Is there documentation that a procoagulant reversal agent was initiated at this hospital? |
|---|
| Format: |
| Length: | 1 |
|---|
| Type: | Alphanumeric |
|---|
| Occurs: | 1 |
|---|
|
|---|
| Allowable Values: |
Y (Yes) A procoagulant reversal agent was initiated at this hospital.
N (No) A procoagulant reversal agent was not initiated at this hospital, OR unable to determine from medical record documentation.
|
|---|
| Notes for Abstraction: |
- If a procoagulant reversal agent was initiated at this hospital, select “Yes”.
- Only accept reversal agents identified in the list of inclusions. No other terms for reversal agents will be accepted.
- If Vitamin K only was administered as the sole form of reversal and no other procoagulant agent was administered, select “No”.
|
|---|
| Suggested Data Sources: |
- Emergency department record
- Nursing flow sheet
- Progress notes
- Medication administration record (MAR)
- Medication reconciliation form
|
|---|
| Additional Notes: |
|
|---|
| Guidelines for Abstraction: |
|---|
| Inclusion |
Exclusion |
- Activated prothrombin complex concentrates
- Anti-inhibitor coagulant complex
- Autoplex T
- Bebulin VH
- Eptacog alfa
- Factor IX Complex
- Factor VIIa (Recombinant)
- Feiba VH Immuno
- Fresh frozen plasma (FFP)
- NovoSeven
- NovoSeven RT
- Profilnine SD
- Proplex T
- Prothrombin complex concentrates (PCCs
- rFVIIa
- (Kcentra) PCC-Human
- Pradaxa (dabigatran) reversal agent: Praxbind (idarucizumab)
|
- Vitamin K Only
- Factor IX (without complex)
|
|